Shire (SHPG) Accounts Payable & Accrued Expense : $4,025 Mil (As of Sep. 2018)

View and export this data going back to 1998. Start your Free Trial

What is Shire Accounts Payable & Accrued Expense?

Shire's quarterly accounts payable & accrued expense declined from Mar. 2018 ($3,939 Mil) to Jun. 2018 ($3,889 Mil) but then increased from Jun. 2018 ($3,889 Mil) to Sep. 2018 ($4,025 Mil).

Shire's annual accounts payable & accrued expense increased from Dec. 2015 ($696 Mil) to Dec. 2016 ($1,616 Mil) and increased from Dec. 2016 ($1,616 Mil) to Dec. 2017 ($2,208 Mil).

Shire Accounts Payable & Accrued Expense Historical Data

The historical data trend for Shire's Accounts Payable & Accrued Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Shire Accounts Payable & Accrued Expense Chart

Shire Annual Data

Trend

Dec08

Dec09

Dec10

Dec11

Dec12

Dec13

Dec14

Dec15

Dec16

Dec17

Accounts Payable & Accrued Expense

Get a 7-Day Free Trial

379.70

584.10

695.90

1,615.60

2,208.30

Shire Quarterly Data
	Dec13	Mar14	Jun14	Sep14	Dec14	Mar15	Jun15	Sep15	Dec15	Mar16	Jun16	Sep16	Dec16	Mar17	Jun17	Sep17	Dec17	Mar18	Jun18	Sep18
Accounts Payable & Accrued Expense	Get a 7-Day Free Trial															3,870.50	2,208.30	3,939.00	3,888.50	4,025.10

Shire Accounts Payable & Accrued Expense Calculation

Accounts payable & accrued expense usually includes accounts payable, accrued compensation and related benefits, etc.

Accounts payable is money owed by a business to its suppliers shown as a liability on a company's balance sheet. It is distinct from notes payable liabilities, which are debts created by formal legal instrument documents.

It is part of the current portion of the liabilities (due within one year or within the normal operating cycle if longer) reflected on the balace sheet of the company. A higher Accounts Payable means lower Working Capital needed to operate the business.

Shire (SHPG) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Shire PLC (NAS:SHPG) » Definitions » Accounts Payable & Accrued Expense

Comparable Companies

Traded in Other Exchanges

N/A

Address

Website

http://www.shire.com

Shire is a diversified, Ireland-based specialty drug firm. Shire has grown primarily through mergers and acquisitions, including the Transkaryotic Therapies acquisition in 2005, which established its genetic disease business with Replagal and Elaprase, and the merger with New River in 2007, which brought full rights to neuroscience drug Vyvanse. Shire completed the acquisition of ViroPharma (genetic diseases) in 2014, NPS Pharma (internal medicine) in 2015, and Baxalta (hematology, immunology, and oncology) and Dyax (genetic diseases) in 2016.

Executives

James H Cavanaugh

director

265 HOTHORPE LANE, VILLANOVA PA 19085